Join AMNet: An Addiction Medicine Practice-Based Research Network

AMNet is a network of office-based addiction medicine prescribers working to address the opioid epidemic and improve patient outcomes.

Your Participation Makes a Difference

A collaborative initiative from APA, American Society of Addiction Medicine (ASAM), Friends Research Institute (FRI), and the National Institute on Drug Abuse (NIDA), AMNet is seeking addiction medicine providers from a range of practices to participate in a practice-based research network. The network is focused on measuring and improving patient outcomes through the collection of data in PsychPRO - APA's CMS-Qualified Clinical Data Registry. AMNet will be able to serve as a platform for future research studies.

AMNet participants will gain complimentary access to PsychPRO and receive free CME clinical and research webinars to address the opioid epidemic. Contribute to this important effort focused on measuring and improving your practice's patient outcomes while building capacity to participate in future research if desired.

Complete this 5-minute survey to describe your practice and check your eligibility for AMNet.

Take Survey

About AMNet

Addiction medicine and addiction psychiatry office-based practices play an important role in responding to our nation's devastating opioid epidemic. Yet, little is known about the type of patients treated in these practices, the services they receive, and their clinical outcomes. Practices often have limited opportunities to organize their patient data to inform quality improvement efforts and are rarely invited to participate in clinical research. Although much is known about opioid treatment programs (OTP) and their patients, relatively little is known about providers and the patients they treat for substance use disorders in non-OTP outpatient programs, community health centers, and community mental health centers.

With funding support from the Patient-Centered Outcomes Research Trust Fund, AMNet was created as a joint initiative to address the nation's opioid epidemic and fill the gap in data by forging a practice-based research network.

AMNet participants will receive complimentary access to PsychPRO, APA's CMS-Qualified Clinical Data Registry for use in addiction medicine practices. PsychPRO has successfully integrated with over 15 electronic health record systems offering clinician- and patient-reported outcome measures, accessible via its clinician and patient portals, and an interactive dashboard to visualize patient-level information and facilitate data comparisons for quality improvement initiatives.

AMNet's patient-reported outcome measures in PsychPRO include:

  • Brief Addiction Monitor (BAM)
  • TAPS Tool
  • Treatment Effectiveness Assessment (TEA)
  • Short Opiate Withdrawal Scale (SOWS)
  • Clinicial Opiate Withdrawal Scale (COWS)
  • Visual Analogue Scale for Opioid Craving (VAS)
  • Patient Health Questionnaire (PHQ-2)
  • PROMIS Pain Interference
  • ...and more.

PsychPRO's Interactive Dashboard Preview:

Click each image below for more dashboard views:

Who Should Participate in AMNet?

We are seeking providers including physicians, nurse practitioners, and physician assistants who prescribe any formulations of buprenorphine or naltrexone in a wide variety of outpatient settings, including:

  • Office-based Opioid Treatment Practices (OBOTs)
  • Intensive Outpatient Programs (IOPs)
  • Outpatient Programs (OPs)
  • Community Health Centers (CHCs, FQHCs)
  • Community Mental Health Centers (CMHCs)

Practices in health care and academic institutions, with or without EHRs, that regularly treat patients with opioid use and other substance use disorders are welcome. Practices can be located in urban, suburban, or rural areas. Telemedicine practices are eligible. We are currently not seeking providers in opioid treatment programs because more is known about their patient outcomes than in other settings.

Providers are eligible regardless of their membership status in APA, American Association of Addiction Psychiatry (AAAP), or ASAM.

Benefits of Joining AMNet

  • Free access to PsychPRO to virtually engage with patients, track patient success, inform quality improvement efforts, and create reports for stakeholders
  • Access to free CME-approved training webinars on addiction medicine and clinical research
  • Potential credit toward MOC Part IV Certification
  • Opportunity to participate in future clinical research studies
  • Free tablet computer
  • $1,000 Honorarium
  • Opportunity to participate in future clinical research studies

Complete the Survey Today

We would like to hear from you regardless of whether you wish to join AMNet.

Below is a link to a 5-minute survey to describe your practice. A nationwide response to the survey will help us learn more about the diverse characteristics of practices and their patients.

At the end of the survey you can indicate your interest in joining AMNet or request additional information.

Take Survey


Contact Us

If you have additional questions you are invited to contact us at

Contact Us

Funded by NIH/NIDA Grant Award: 3U01DA046910-02S2